Course in the Ward Oxygen saturation was 85-88% despite oxygen per mask at 5-6 lpm. She was nebulized with salbutamol and post-nebulization parameters.

Slides:



Advertisements
Similar presentations
Bronchodilators and Other Respiratory Agents
Advertisements

Use of Medications in Asthma Cyril Grum, M.D. Department of Internal Medicine *Based on the University of Michigan Guidelines for Clinic Care and the National.
Respiratory Pharmacology Dr Mike Iredale October 2010.
RESPIRATORY PHARMACOLOGY. S+S OF RESPIRATORY CONDITIONS (ASTHMA AND COPD) SOB Cough Wheezing Tight chest.
Copyright © The McGraw-Hill Companies, Inc. Permission required for reproduction or display. 1 CHAPTER 32 Bronchodilator Drugs and the Treatment of Asthma.
Respiratory Medications Theresa Till Ed.D, RN,CCRN.
1 Copyright © 2012, 2008, 2002, 1998, 1994, 1989, 1984, 1978 by Mosby, Inc., an affiliate of Elsevier Inc. Reminder:  QUIZ NEXT WEEK ON:  Anti-infectives,
Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 37 CHAPTER 37 Bronchodilators and Other Respiratory.
Management of COPD & Asthma Melissa Brittle & Jessica Macaro.
Drugs For Treating Asthma
Treatment of asthma By Prof. Hanan Hagar.
Respiratory drugs -Surag Khadka. Learning outcomes Classes of drugs MoA of the following Beta-2 agonists Anti-cholinergics Leukotriene antagonists Methylxanthines.
Medications for the Acute Management of Asthma A. Shaun Rowe, Pharm.D., BCPS.
Pharmacology of drugs used in bronchial asthma & COPD
Respiratory System PHARMACOLOGY Dr Nasim Ullah Siddiqui.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 76 Drugs for Asthma.
Chronic Obstructive Pulmonary Disease. Why COPD is Important ? COPD is the only chronic disease that is showing progressive upward trend in both mortality.
Asthma Medications ESAT 4001 Pharmacology in Athletic Training.
Bronchial Asthma  Definition  Patho-physiology  Diagnosis  Management.
DRUGS USED IN ASTHMA. Asthma is an inflammatory disease of the airways characterized by episodes of acute bronchoconstriction causing shortness of breath,
Drugs used in asthma & COPD By Dr. Mahmoud A. Naga.
Case No. 12 SH, 25 years old with a history of asthma since childhood presented to the OPD clinic with complaints of worsening dyspnea and wheezing. He.
MANAGEMENT OF ASTHMA 6 Penaflor, Dominic Quinto, Milraam Ramos,Josefa Victoria Sicat, Gracie Suaco, David Tio- Cuizon, Jeremiah Valenzuela, Virginia Lou.
Bronchial Asthma  Definition  Patho-physiology  Diagnosis  Management.
Management of patients with allergic disorders. ASTHMA MANAGEMENT.
Treatment of asthma By Prof. Hanan Hagar. Disorders of Respiratory Function Classification Main disorders of the respiratory system are : 1. Bronchial.
 Definition  Asthma is a chronic inflammatory disorder of the lung airways, characterised by reversible airway obstruction, airway hyper-responsiveness,
Anticholinergics in COPD presented by: Soha Ragab Moselhy group 2.
1 DRUGS AFFECTING RESPIRATORY SYSTEM. 2 ASTHMA chronic inflammatory airway disease excessive tracheobronchial reactivity SYMPTOMS wheezing, chest tightness,
Drugs used in asthma By S.Bohlooli, PhD. Asthma therapy Short term relievers Bronchodilators Long term controllers Anti-inflammatory agent Leukorienes.
Drugs Used to Treat Lower Respiratory Disease
Bronchodilators Lilley Pharmacology Text: Chapter 35
PTP 546 Module 7 Respiratory Pharmacology
Mosby items and derived items © 2008, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 6 Adrenergic (Sympathomimetic) Bronchodilators.
Chapter 9 Respiratory System Drugs Copyright © 2011 Delmar, Cengage Learning.
Pharmacology of drugs used in bronchial asthma & COPD
PHARMACOLOGY OF RESPIRATORY DRUGS Susanne Young May 04’
PHARMACOTHERAPY OF RESPIRATORY DISEASES. Bronchial asthma Bronchial asthma is a disease caused by increased responsiveness of the tracheobronchial tree.
Short acting anti-cholinergic Ipratropium
Treatment of Bronchial Asthma I D. Laila.M. Matalqah Respiratory System Faculty of Medicine 1.
Bronchodilators and Other Respiratory Agents
Asthma.
Drugs affecting the respiratory system. Main disorders of the respiratory system are 1.Bronchial asthma. 2.Chronic obstructive pulmonary disease (COPD).
1 © 2013 Cengage Learning. All Rights Reserved. May not be copied, scanned, or duplicated, in whole or in part, except for use as permitted in a license.
Clinical pharmacology of drugs acting on the respiratory organs function.
Drugs Used to Treat Asthma Dr. Najlaa Saadi Ismael Department of Pharmacology Mosul college of Medicine University of Mosul.
Asthma Asthma is characterized clinically by recurrent bouts of coughing, shortness of breath, chest tightness, and wheezing; physiologically by.
Allergic Rhinitis- inflammation of the nasal airways from an allergen (dust, pollen, animal dander). Symptoms runny noseitching eye rednessswelling Treatment-
MD. HAMZA ALBEE ASHANIA AKHTER TASNOVA NOWRIN KANZIL MAULA MOU RUBAIYAT ISLAM MONA AFRIN A RAHMAN AIRIN NAHER SHAGUFTA JASMIN SUBI.
Helmi Lubis, dr, SpAK Ridwan M. Daulay, dr, SpAK Wisman Dalimunthe, dr, SpA Rini S. Daulay, dr, M.Ked(Ped), SpA.
β2 Agonists Albuterol and other inhaled short-acting selective β2 agonists are indicated for treatment of intermittent episodes of bronchospasm and are.
Asthma ( Part 1 ) Dr.kassim.M.sultan F.R.C.P. Objectives: 1-Define asthma 2-Identify its aggravating factors 3-Describe its clinical features 4-Illustrate.
Management Of Asthma With Acute Exacerbation In Pediatric Patients Speaker : Dr. Meng-Shu Wu.
Department of Pharmacology
Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc.1 Respiratory Medications.
Asthma Review of Pathophysiology and Treatment. n definition of asthma –Asthma is a chronic inflammatory disorder of the airways in which many cells &
Pharmacology of Anti- Asthmatic Medications
Respiratory System Hmzeh Elayan
Pharmacology of drugs used in bronchial asthma & COPD
Drugs in obstructive lung diseases
Chapter 9 Respiratory Drugs.
Drugs affecting the respiratory system
Chapter 32 Airway Pharmacology
Nonsteroidal antiasthma agents
Drugs Affecting the Respiratory System
Pharmacology of drugs used in bronchial asthma & COPD
Drugs used in asthma.
ASTHMA Dr. Saviour K. Assoah (Medicine Dept). OUTLINE Definition Epidemiology Risks / precipitating factors Symptoms and signs Pathophysiology Types of.
Presentation transcript:

Course in the Ward Oxygen saturation was 85-88% despite oxygen per mask at 5-6 lpm. She was nebulized with salbutamol and post-nebulization parameters were as follows: – RR 20 cpm – CR 120 bpm – Fair air entry – Loud wheezes and crackles, both lung fields

Workups Workups that can be done in our patient include: – Pulse Oximetry – Pulmonary function Test (Spirometry or Peak flow meter) – Arterial Blood Gas – Chest X-ray

Managing Asthma in Acute Exacerbation Source: Global Strategy for Asthma Control and Prevention: GINA Guidelines 2009

Drugs for Acute Asthma Bronchodilators – Anticholinergics – Methylxanthines – Sympathomimetics Catecholamines – epinephrine B2 agonists – SABA Anti-inflammatory – Corticosteroids Systemic Inhaled

Relievers Quickly reverse bronchoconstriction during acute exacerbation or breakthrough symptoms; taken prn Bronchodilators – SABA, epinephrine, methylxanthines Anti-inflammatory agents – Systemic steroids

Controllers Have to be taken continuously on a maintenance basis to control asthma Bronchodilators – LABA Anti-inflammatory agents – Inhaled – Systemic – LT antagonists – Mast cell stabilizers

Bronchodilators MOA: activation of B receptors -> activation of Gs coupling proteins -> cAMP -> phosphorylation of target enzymes -> relaxation of bronchial muscles Epinephrine B2 agonists

Epinephrine For anaphylaxis Not effective in oral intake Rapidly conjugated and oxidized in GIT and liver a1= a2 ; B1=B2 Triggers sympathetic response, fear, anxiety, tenseness, restlessness, cardiac arrythmias Not used in acute asthma, unless not responsive to B2 agonist or asthma is caused by anaphylaxis

SABA Terbutaline Salbutamol After oral inhalation, 10% deposited in bronchial airway where absorption takes place -> systemic circulation. No substantial effect on inflammation

B2 Agonists SABA – Oral Peak effect 2 hrs Duration of action 4-8 hrs – Inhaled Peak effect mins, 75% of maximum bronchodilation by 5 mins >4 hrs

Adverse Effects of B2 agonists Skeletal muscle tremors tachycardia, arrthymias increased bronchial hyperreactivity and deterioration of disease control

Anticholinergic Drugs Ipratropium bromide: treatment for asthma Binds M2 and M3 receptors with equal affinity, competitive antagonist to acetylcholine at M3 receptors on smooth muscles -> blocking bronchospasm -> decrease mucus secretion In combination with SABA, provides quick relief for acute asthma attack

Combivent contains a microcrystalline suspension of ipratropium bromide and salbutamol in a pressurized metered-dose aerosol unit for oral inhalation administration. The 200 inhalation unit has a net weight of 14.7 grams. Anticholinergic bronchodilator Each actuation meters 21 mcg of ipratropium bromide and 120 mcg of salbutamol from the valve and delivers 18 mcg of ipratropium bromide and 103 mcg of salbutamol from the mouthpiece.

Dosage 2 inhalations four times a day. Patients may take additional inhalations as required; however, the total number of inhalations should not exceed 12 in 24 hours. Safety and efficacy of additional doses of COMBIVENT Inhalation Aerosol beyond 12 puffs/24 hours have not been studied.

All Adverse Events (in percentages), from Two Large Double-blind, Parallel, 12-Week Studies of Patients with COPD

Methylxanthines Theophylline – both bronchodilator and anti- inflammatory actions inhibits PDE -> increases cAMP ->smooth muscle relaxation High level of toxicity; narrow therapeutic index AE: nausea, vomiting, GIT disturbances, headache,

Corticosteroids Anti-inflammatory effects due to inhibition of production of pro-inflammatory cytokines -> decreased trafficking of lymphocytes, eosinophils -> decreased bronchial hyperreactivity Potentiates B2 agonist effect by increasing synthesis of B2 receptors Decrease mucus production

Corticosteroids Systemic steroids – Oral: prednisone, prednisolone, methylprednisolone – Parenteral: hydrocortisone, methylprednisolone Inhaled steroids – Budesonide, fluticasone

Indications of CS Systemic steroids – For relief of acute asthma exacerbations – Control of severe persistent asthma Inhaled steroids – As maintenance therapy for all levels of persistent asthma

Adverse Effects of CS Inhaled CS adverse effects: hoarseness/dysphonia, oral candidiasis, throat irritation and cough Systemic CS adverse effects: truncal obesity, moon facies, buffalo hump, osteoporosis